Dong-Young Noh Selected Research

Therapeutics

1/2021	Intensity of metastasis screening and survival outcomes in patients with breast cancer.
4/2020	Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients.
5/2019	Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort.
1/2019	Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients.
10/2017	Can We Skip Intraoperative Evaluation of Sentinel Lymph Nodes? Nomogram Predicting Involvement of Three or More Axillary Lymph Nodes before Breast Cancer Surgery.
1/2017	The treatment outcomes and the use of adjuvant therapies in breast cancer patients with severe co-morbidities.
2/2016	Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer.
1/2016	Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer.
9/2015	Radioactive Iodine Therapy Did Not Significantly Increase the Incidence and Recurrence of Subsequent Breast Cancer.
7/2015	Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dong-Young Noh Research Topics

Disease

224	Breast Neoplasms (Breast Cancer) 12/2021 - 07/2002
131	Neoplasms (Cancer) 12/2021 - 07/2002
24	Triple Negative Breast Neoplasms 12/2021 - 11/2007
21	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2009
7	Lymphatic Metastasis 08/2016 - 12/2009
6	Carcinogenesis 12/2020 - 12/2005
4	Pathologic Complete Response 07/2020 - 12/2012
3	Ductal Carcinoma 11/2015 - 12/2005
3	Obesity 09/2015 - 12/2012
3	Thyroid Neoplasms (Thyroid Cancer) 09/2015 - 03/2007
2	Inflammation (Inflammations) 12/2020 - 01/2017
2	Dyslipidemias (Dyslipidemia) 12/2020 - 02/2009
2	Hypoxia (Hypoxemia) 08/2016 - 03/2008
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2016 - 01/2010
2	Residual Neoplasm 04/2015 - 01/2013
2	Disease Progression 03/2013 - 08/2012
2	Margins of Excision 08/2012 - 05/2011
2	Noninfiltrating Intraductal Carcinoma (DCIS) 04/2012 - 03/2002

Drug/Important Bio-Agent (IBA)

44	Estrogen ReceptorsIBA 01/2021 - 11/2003
38	Hormones (Hormone)IBA 01/2021 - 11/2006
29	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2003
20	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 06/2005
18	human ERBB2 proteinIBA 01/2019 - 10/2008
15	Biomarkers (Surrogate Marker)IBA 04/2020 - 01/2008
13	Estrogens (Estrogen)FDA Link 05/2021 - 03/2003
13	Phenobarbital (Luminal)FDA Link 01/2020 - 06/2004
11	Tamoxifen FDA LinkGeneric 12/2020 - 06/2003
11	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2017 - 04/2007
9	Docetaxel (Taxotere)FDA Link 06/2016 - 11/2007
8	Messenger RNA (mRNA)IBA 01/2021 - 07/2002
8	Biological ProductsIBA 08/2016 - 12/2007
7	Small Interfering RNA (siRNA)IBA 05/2020 - 01/2009
6	Transcription Factors (Transcription Factor)IBA 01/2021 - 04/2013
6	AnthracyclinesIBA 10/2020 - 04/2012
6	DNA (Deoxyribonucleic Acid)IBA 11/2015 - 09/2006
6	ORALIT (ORS)IBA 07/2013 - 11/2004
5	Metformin (Glucophage)FDA LinkGeneric 06/2021 - 03/2014
5	Pharmaceutical PreparationsIBA 01/2021 - 01/2008
5	Aromatase InhibitorsIBA 12/2020 - 07/2012
5	MicroRNAs (MicroRNA)IBA 01/2019 - 12/2011
5	taxaneIBA 04/2016 - 01/2012
5	Trastuzumab (Herceptin)FDA Link 12/2014 - 05/2011
4	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 04/2007
4	EnzymesIBA 01/2021 - 02/2003
4	ErbB Receptors (EGF Receptor)IBA 10/2017 - 03/2012
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2016 - 04/2007
4	Epidermal Growth Factor (EGF)IBA 04/2016 - 11/2004
4	ProteomeIBA 10/2010 - 01/2008
4	Glutathione Transferase (Glutathione S-Transferase)IBA 11/2004 - 03/2003
3	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2021 - 04/2012
3	RNA (Ribonucleic Acid)IBA 12/2020 - 03/2010
3	Letrozole (Femara)FDA LinkGeneric 04/2017 - 01/2014
3	Sirtuin 1IBA 02/2016 - 07/2015
3	Contrast MediaIBA 08/2014 - 07/2002
3	AntioxidantsIBA 02/2012 - 08/2002
3	Complementary DNA (cDNA)IBA 07/2010 - 09/2005
3	Codon (Codons)IBA 03/2008 - 01/2004
3	Estrogen Receptor alphaIBA 02/2005 - 07/2003
2	Butyrates (Butyrate)IBA 06/2021 - 06/2016
2	Phospholipases (Phospholipase)IBA 01/2021 - 04/2005
2	LipidsIBA 01/2021 - 03/2016
2	Phosphotransferases (Kinase)IBA 04/2020 - 01/2012
2	Androgen Receptors (Androgen Receptor)IBA 04/2020 - 02/2015
2	Peptides (Polypeptides)IBA 12/2019 - 02/2013
2	CytokinesIBA 01/2019 - 03/2005
2	Genetic Markers (Genetic Marker)IBA 10/2018 - 01/2015
2	IntegrinsIBA 05/2017 - 05/2013
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 03/2017 - 08/2012
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 10/2011
2	Indicators and Reagents (Reagents)IBA 08/2016 - 02/2016
2	Protein Isoforms (Isoforms)IBA 03/2016 - 07/2007
2	Blood Proteins (Serum Proteins)IBA 11/2015 - 10/2011
2	ChromatinIBA 01/2015 - 05/2009
2	LeptinIBA 01/2014 - 06/2013
2	AdipokinesIBA 01/2014 - 06/2013
2	8-hydroxyguanineIBA 12/2013 - 05/2003
2	Progesterone FDA LinkGeneric 12/2013 - 06/2008
2	Riboflavin (Vitamin B2)FDA LinkGeneric 08/2012 - 01/2010
2	Folic Acid (Vitamin M)FDA LinkGeneric 08/2012 - 01/2010
2	AcetyltransferasesIBA 02/2012 - 07/2003
2	VitaminsIBA 02/2012 - 01/2010
2	Glycoproteins (Glycoprotein)IBA 10/2011 - 05/2009
2	AutoantibodiesIBA 10/2010 - 05/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2010 - 08/2002
2	BerberineIBA 11/2008 - 01/2008
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2007 - 08/2002
2	antineoplaston A10 (A 10)IBA 11/2007 - 08/2002

Therapy/Procedure

34	Neoadjuvant Therapy 07/2020 - 11/2007
28	Therapeutics 01/2021 - 04/2007
24	Drug Therapy (Chemotherapy) 10/2020 - 11/2007
14	Segmental Mastectomy (Lumpectomy) 01/2021 - 02/2009
10	Radiotherapy 12/2016 - 11/2007
7	Mastectomy (Mammectomy) 01/2021 - 02/2010
7	Adjuvant Chemotherapy 01/2020 - 12/2004
4	Lymph Node Excision (Lymph Node Dissection) 11/2017 - 02/2009
2	Mammaplasty (Breast Reconstruction) 01/2020 - 03/2016
2	Adjuvant Radiotherapy 01/2019 - 05/2011
2	Transplantation 11/2015 - 03/2012
2	Conservative Treatment 01/2011 - 11/2007
2	Thyroidectomy 12/2007 - 03/2007